beta-amyloid 38 (Aβ38) antibody and antigen (Recombinant protein)
Diagnostic beta-amyloid 38 (Aβ38) antibodies (anti-beta-amyloid 38, anti-Aβ38) and antigens (recombinant beta-amyloid 38 (Aβ38) protein) for Neurodegenerative diseases Aβ38 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
제품 정보
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-Aβ38-Ag01 | Beta-amyloid 38 (Aβ38) antigen | $3090.00 |
GMP-h-Aβ38-Ab01 | Anti-human Aβ38 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ38-Ab02 | Anti-human Aβ38 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ38-Ab03 | Anti-human Aβ38 human monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ38-Ab04 | Anti-human Aβ38 human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
제품 설명
Cat No. of Pruducts | GMP-h-Aβ38-Ag01 |
Product Name | Beta-amyloid 38 (Aβ38) antigen |
Target/Biomarker | beta-amyloid 38 (Aβ38) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | synthesized |
Isotypes | NA |
Bioactivity validation | beta-amyloid 38 (Aβ38) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation |
Products description | Beta-amyloid 38 (Aβ38) antigen is synthesized |
Purity | Purity: ≥95% (HPLC) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-Aβ38-Ab01,GMP-h-Aβ38-Ab02 |
Product Name | Anti-human Aβ38 mouse monoclonal antibody (mAb) |
Target/Biomarker | beta-amyloid 38 (Aβ38) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Aβ38 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-Aβ38-Ab03,GMP-h-Aβ38-Ab04 |
Product Name | Anti-human Aβ38 human monoclonal antibody (mAb) |
Target/Biomarker | beta-amyloid 38 (Aβ38) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human Aβ38 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
참고 문헌
검증 데이터
Click to get more Data / Case study about the product.
Target/Biomarker 정보
Higher CSF Aβ38 levels are associated with lower risk of AD-related changes in 2 independent clinical cohorts. Meta-analysis of 17 studies did not show a convincing difference between Alzheimer’s disease patients and controls: the effect size was quite small (0.921) and the p value was only marginally significant (0.03).
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.